News

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has received a project grant as part of a consortium.

The shift from volume- to performance-based payment is propelling life sciences companies to seek concrete data and medical evidence – both to understand patient care and to demonstrate the effectiveness, safety and value of drug therapies.

INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).

Quintiles announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program.

ERT announced the launch of the Insights Cloud™, a suite of data analytics, visualization, and workflow applications.

Clinipace Worldwide has announced the takeover of Accovion, a CRO with a head office in Frankfurt (Eschborn), Germany.

Accovion Strengthens Clinipace’s Operational and Therapeutic Expertise Within Europe

Researchers at the University of Manchester and Central Manchester University Hospitals NHS Foundation Trust (CMFT) have published new data about public knowledge of, and interest in, the process of medicines R&D.

ArisGlobal, a leading provider of solutions to the life sciences industry, has today announced the availability of agFileMaster; a Cloud-based electronic trial master file.

The team behind Clinical Conductor CTMS recently debuted new functionality that allows healthcare organizations to better manage adaptive and dynamic clinical research that is becoming more relevant in the industry every year.

Three new academic programs have been added to the PAREXEL Academy which span the globe and are designed to prepare students for careers in the biopharmaceutical industry.

The use and number of cognitive-enhancing drugs is likely to grow substantially in the coming years, and researchers must prioritize the potential advantages and dangers of their use in healthy subjects, according to U.K. neuroscientists writing in The Lancet Psychiatry journal.

In a crucial part of the European Patients’ Academy (EUPATI) strategy, 47 patients and patient representatives from across Europe are meeting this week in Barcelona, Spain, to continue their 13-month online training course to become expert patients in the medicines development process.

Denis Lacombe, M.D., has been appointed Director General of the Brussels-based European Organisation for Research and Treatment of Cancer (EORTC).

TransCelerate BioPharma has established two new global initiatives in the clinical trials area. Both initiatives - Placebo / Standard of Care Data Sharing and Electronic Labels for Clinical Trials (e-Labels), are made possible through the collaboration of participating Member Companies.

In a move designed to both tout the importance of precision and to improve the sponsor experience in conducting cardiac safety assessment, iCardiac Technologies announced a full risk-sharing program for Thorough QT studies.

Sponsors Are Guaranteed to Receive Precise, Conclusive Thorough QT Results or Pay Nothing

The use and number of cognitive-enhancing drugs is likely to grow substantially in the coming years, and researchers must prioritize the potential advantages and dangers of their use in healthy subjects, according to U.K. neuroscientists writing in The Lancet Psychiatry journal.